The U.S. federal court ruling that President Trump had overstepped his authority on imposing tariffs marked a clear setback ...

The U.S. federal court ruling that President Trump had overstepped his authority on imposing tariffs marked a clear setback ...

Quantum-enhanced drug discovery emerges as a leading investment trend within the pharmaceutical sector for 2025. Since the ...

Despite regulation changes in the Chinese healthcare industry, we think CSPC is well-positioned to maintain relatively strong revenue growth. First, generic drugs normally face the most severe price ...

Roche's investment is the latest example of the growing appeal of China as a strategic hub for global pharmaceutical manufacturing and innovation. In fact, Roche is not alone, other multinational ...

FRANKFURT, Germany, May 29, 2025 /CNW/ -- Qualifyze, already the global leader in third-party audit services for the ...

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

The administration of US President Donald Trump has taken a series of actions since January, 2025 that directly threaten the ...

Pharma company stocks tumbled after Donald Trump announced a plan to reduce U.S. drug prices, but regained some ground on belief the plan would be hard to implement Drug prices are expected to decline ...

While the Trump administration’s threat of pharmaceutical import tariffs and most favored nation (MFN) drug pricing has ...

How unfortunate if taxes restrain the global cooperation so essential to progress, including life-saving cures.